Safety and Efficacy Study of SUN-131 Transdermal System (TDS) as Compared to Placebo TDS in Patients With a Chalazion
Status:
Completed
Trial end date:
2018-08-17
Target enrollment:
Participant gender:
Summary
This protocol for SUN-131 1.5% TDS is developed for the treatment of chalazion. SUN-131 1.5%
TDS is designed for local delivery of a corticosteroid, to the upper or lower eyelid. The
purpose of this study is to evaluate the efficacy and safety of SUN-131 1.5% TDS as compared
with placebo TDS in the treatment of a chalazion.